Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

PRNewsWire

04 Aug 2026, 01:43 UTC · 1h ago

Erasca, Inc. Deadline: ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

Erasca, Inc. Deadline: ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

What the story claims

3 claims · each scored for market impact

What matters in this story

1
Erasca, Inc. (NASDAQ: ERAS) is facing a securities fraud class action lawsuit alleging false and misleading statements regarding its lead oncology drug candidate, ERAS-0015. — Allegations of fraud and misleading claims regarding a lead product candidate typically create significant downward pressure on biotech stock prices due to increased risk and potential liability.
-0.60
2
The lawsuit claims Erasca's preclinical comparisons of ERAS-0015 against a competitor's drug (RMC-6236) were improper and lacked a reasonable basis. — This specifically undermines the competitive positioning and perceived efficacy of the company's primary asset, which is a core driver of its valuation.
-0.40
3
The legal complaint alleges that Erasca's claims exposed the company to patent and trade secret disputes. — Intellectual property disputes introduce legal uncertainty and risk to the company's future exclusivity and revenue potential.
-0.30

6 related stories

Newsfile Corp
1h ago
ERASCA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action - ERAS
- biotech
- class action
- investor rights
Read

Erasca, Inc. Deadline: ER… — ERAS -1.00 | NewsImpactScreener

Erasca, Inc. Deadline: ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

What matters in this story

ERASCA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action - ERAS

Erasca, Inc. Deadline: ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

What matters in this story

ERASCA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action - ERAS

How each ticker is affected

Connected tickers

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026

BRCB DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Black Rock Coffee Bar, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BRCB

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

Erasca, Inc. Deadline: ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

What matters in this story

Next reads from the same story arc

ERASCA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action - ERAS

Erasca, Inc. Deadline: ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

What matters in this story

Next reads from the same story arc

ERASCA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action - ERAS

How each ticker is affected

Connected tickers

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026

BRCB DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Black Rock Coffee Bar, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BRCB

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit